BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30606716)

  • 1. Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium.
    Muller DC; Larose TL; Hodge A; Guida F; Langhammer A; Grankvist K; Meyer K; Cai Q; Arslan AA; Zeleniuch-Jacquotte A; Albanes D; Giles GG; Sesso HD; Lee IM; Gaziano JM; Yuan JM; Hoffman Bolton J; Buring JE; Visvanathan K; Le Marchand L; Purdue MP; Caporaso NE; Midttun Ø; Ueland PM; Prentice RL; Weinstein SJ; Stevens VL; Zheng W; Blot WJ; Shu XO; Zhang X; Xiang YB; Koh WP; Hveem K; Thomson CA; Pettinger M; Engström G; Brunnström H; Milne RL; Stampfer MJ; Han J; Johansson M; Brennan P; Severi G; Johansson M
    BMJ; 2019 Jan; 364():k4981. PubMed ID: 30606716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3).
    Muller DC; Hodge AM; Fanidi A; Albanes D; Mai XM; Shu XO; Weinstein SJ; Larose TL; Zhang X; Han J; Stampfer MJ; Smith-Warner SA; Ma J; Gaziano JM; Sesso HD; Stevens VL; McCullough ML; Layne TM; Prentice R; Pettinger M; Thomson CA; Zheng W; Gao YT; Rothman N; Xiang YB; Cai H; Wang R; Yuan JM; Koh WP; Butler LM; Cai Q; Blot WJ; Wu J; Ueland PM; Midttun Ø; Langhammer A; Hveem K; Johansson M; Hultdin J; Grankvist K; Arslan AA; Le Marchand L; Severi G; Johansson M; Brennan P
    Ann Oncol; 2018 Jun; 29(6):1468-1475. PubMed ID: 29617726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein and risk of lung cancer.
    Chaturvedi AK; Caporaso NE; Katki HA; Wong HL; Chatterjee N; Pine SR; Chanock SJ; Goedert JJ; Engels EA
    J Clin Oncol; 2010 Jun; 28(16):2719-26. PubMed ID: 20421535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).
    Huang JY; Larose TL; Luu HN; Wang R; Fanidi A; Alcala K; Stevens VL; Weinstein SJ; Albanes D; Caporaso NE; Purdue MP; Ziegler RG; Freedman ND; Lan Q; Prentice RL; Pettinger M; Thomson CA; Cai Q; Wu J; Blot WJ; Shu XO; Zheng W; Arslan AA; Zeleniuch-Jacquotte A; Le Marchand L; Wilkens LR; Haiman CA; Zhang X; Stampfer MJ; Han J; Giles GG; Hodge AM; Severi G; Johansson M; Grankvist K; Langhammer A; Hveem K; Xiang YB; Li HL; Gao YT; Visvanathan K; Ueland PM; Midttun Ø; Ulvi A; Buring JE; Lee IM; Sesso HD; Gaziano JM; Manjer J; Relton C; Koh WP; Brennan P; Johansson M; Yuan JM
    Int J Cancer; 2020 May; 146(9):2394-2405. PubMed ID: 31276202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3).
    Fanidi A; Muller DC; Yuan JM; Stevens VL; Weinstein SJ; Albanes D; Prentice R; Thomsen CA; Pettinger M; Cai Q; Blot WJ; Wu J; Arslan AA; Zeleniuch-Jacquotte A; McCullough ML; Le Marchand L; Wilkens LR; Haiman CA; Zhang X; Han J; Stampfer MJ; Smith-Warner SA; Giovannucci E; Giles GG; Hodge AM; Severi G; Johansson M; Grankvist K; Langhammer A; Krokstad S; Næss M; Wang R; Gao YT; Butler LM; Koh WP; Shu XO; Xiang YB; Li H; Zheng W; Lan Q; Visvanathan K; Bolton JH; Ueland PM; Midttun Ø; Ulvik A; Caporaso NE; Purdue M; Ziegler RG; Freedman ND; Buring JE; Lee IM; Sesso HD; Gaziano JM; Manjer J; Ericson U; Relton C; Brennan P; Johansson M
    J Natl Cancer Inst; 2018 Jan; 110(1):57-67. PubMed ID: 28922778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Lipoprotein-Associated Phospholipase A
    Tibuakuu M; Kianoush S; DeFilippis AP; McEvoy JW; Zhao D; Guallar E; Ballantyne CM; Hoogeveen RC; Blaha MJ; Michos ED
    Am J Cardiol; 2018 May; 121(9):1056-1064. PubMed ID: 29525060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).
    Larose TL; Guida F; Fanidi A; Langhammer A; Kveem K; Stevens VL; Jacobs EJ; Smith-Warner SA; Giovannucci E; Albanes D; Weinstein SJ; Freedman ND; Prentice R; Pettinger M; Thomson CA; Cai Q; Wu J; Blot WJ; Arslan AA; Zeleniuch-Jacquotte A; Le Marchand L; Wilkens LR; Haiman CA; Zhang X; Stampfer MJ; Hodge AM; Giles GG; Severi G; Johansson M; Grankvist K; Wang R; Yuan JM; Gao YT; Koh WP; Shu XO; Zheng W; Xiang YB; Li H; Lan Q; Visvanathan K; Hoffman Bolton J; Ueland PM; Midttun Ø; Caporaso N; Purdue M; Sesso HD; Buring JE; Lee IM; Gaziano JM; Manjer J; Brunnström H; Brennan P; Johansson M
    Int J Epidemiol; 2018 Dec; 47(6):1760-1771. PubMed ID: 29901778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
    Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating inflammation markers and prospective risk for lung cancer.
    Shiels MS; Pfeiffer RM; Hildesheim A; Engels EA; Kemp TJ; Park JH; Katki HA; Koshiol J; Shelton G; Caporaso NE; Pinto LA; Chaturvedi AK
    J Natl Cancer Inst; 2013 Dec; 105(24):1871-80. PubMed ID: 24249745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating C-reactive protein increases lung cancer risk: Results from a prospective cohort of UK Biobank.
    Ji M; Du L; Ma Z; Xie J; Huang Y; Wei X; Jiang X; Xu J; Yin R; Wang Y; Dai J; Jin G; Xu L; Zhu C; Hu Z; Ma H; Zhu M; Shen H
    Int J Cancer; 2022 Jan; 150(1):47-55. PubMed ID: 34449869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.
    Pine SR; Mechanic LE; Enewold L; Chaturvedi AK; Katki HA; Zheng YL; Bowman ED; Engels EA; Caporaso NE; Harris CC
    J Natl Cancer Inst; 2011 Jul; 103(14):1112-22. PubMed ID: 21685357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diesel Engine Exhaust Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Exposure-Response Analysis of 14 Case-Control Studies.
    Ge C; Peters S; Olsson A; Portengen L; Schüz J; Almansa J; Ahrens W; Bencko V; Benhamou S; Boffetta P; Bueno-de-Mesquita B; Caporaso N; Consonni D; Demers P; Fabiánová E; Fernández-Tardón G; Field J; Forastiere F; Foretova L; Guénel P; Gustavsson P; Janout V; Jöckel KH; Karrasch S; Teresa Landi M; Lissowska J; Luce D; Mates D; McLaughlin J; Merletti F; Mirabelli D; Pándics T; Parent MÉ; Plato N; Pohlabeln H; Richiardi L; Siemiatycki J; Świątkowska B; Tardón A; Wichmann HE; Zaridze D; Straif K; Kromhout H; Vermeulen R
    Am J Respir Crit Care Med; 2020 Aug; 202(3):402-411. PubMed ID: 32330395
    [No Abstract]   [Full Text] [Related]  

  • 13. Neighbourhood deprivation and lung cancer risk: a nested case-control study in the USA.
    Sanderson M; Aldrich MC; Levine RS; Kilbourne B; Cai Q; Blot WJ
    BMJ Open; 2018 Sep; 8(9):e021059. PubMed ID: 30206077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of Cigarette Smoking With Subclinical Inflammation and Atherosclerosis: ELSA-Brasil (The Brazilian Longitudinal Study of Adult Health).
    Kianoush S; Yakoob MY; Al-Rifai M; DeFilippis AP; Bittencourt MS; Duncan BB; Bensenor IM; Bhatnagar A; Lotufo PA; Blaha MJ
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study.
    Oelsner EC; Balte PP; Bhatt SP; Cassano PA; Couper D; Folsom AR; Freedman ND; Jacobs DR; Kalhan R; Mathew AR; Kronmal RA; Loehr LR; London SJ; Newman AB; O'Connor GT; Schwartz JE; Smith LJ; White WB; Yende S
    Lancet Respir Med; 2020 Jan; 8(1):34-44. PubMed ID: 31606435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study.
    Vineis P; Airoldi L; Veglia F; Olgiati L; Pastorelli R; Autrup H; Dunning A; Garte S; Gormally E; Hainaut P; Malaveille C; Matullo G; Peluso M; Overvad K; Tjonneland A; Clavel-Chapelon F; Boeing H; Krogh V; Palli D; Panico S; Tumino R; Bueno-De-Mesquita B; Peeters P; Berglund G; Hallmans G; Saracci R; Riboli E
    BMJ; 2005 Feb; 330(7486):277. PubMed ID: 15681570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women.
    Ebbert JO; Yang P; Vachon CM; Vierkant RA; Cerhan JR; Folsom AR; Sellers TA
    J Clin Oncol; 2003 Mar; 21(5):921-6. PubMed ID: 12610194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma 7beta-hydroxycholesterol as a possible predictor of lung cancer risk.
    Linseisen J; Wolfram G; Miller AB
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1630-7. PubMed ID: 12496054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung carcinoma in former smokers.
    Tong L; Spitz MR; Fueger JJ; Amos CA
    Cancer; 1996 Sep; 78(5):1004-10. PubMed ID: 8780538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.